NorthStar Medical Radioisotopes, LLC
Ben Nemacheck has worked as a Chemical Process Engineer II at NorthStar Medical Radioisotopes, LLC since August 2022. Prior to that, they worked at Sterling Pharma Solutions as a Process Engineer from July 2021 to August 2022, and as a Production Engineer from September 2020 to July 2021. Before Sterling Pharma Solutions, Ben worked at Alcami Corporation as a Production Engineer from February 2019 to September 2020, and as a Process Chemist from September 2017 to February 2019. Their earliest work experience was as an Annotator at the Biological Magnetic Resonance Bank, UW-Madison from June 2015 to May 2017.
From 2013 to 2017, Ben Nemacheck attended the University of Wisconsin-Madison, where they pursued a Bachelor of Science degree in Chemical Engineering.
NorthStar Medical Radioisotopes, LLC
NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.